Results 31 to 40 of about 103,371 (308)

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Humkinar: Construction of a Large Scale Web Repository and Information System for Low Resource Urdu Language

open access: yesIEEE Access
Online content availability, commercial viability, and technological advancements for English and European languages direct mainstream search engines to prioritize the search results of these high-resource languages.
Muhammad Amir Mehmood, Bilal Tahir
doaj   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

open access: yesMolecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir   +12 more
wiley   +1 more source

Knowledge Management for Injection Molding Defects by a Knowledge Graph

open access: yesApplied Sciences, 2022
Injection molding is a technique with a high knowledge content. However, most of the injection molding knowledge is stored in books, and it is difficult for personnel to clarify the influence of the different factors.
Zhe-Wei Zhou   +3 more
doaj   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Antecedents and Outcomes of Search Engines Loyalty: Designing a model of Iranian Users Loyalty

open access: yesتحقیقات بازار یابی نوین, 2013
This paper aims to design proposed model for search engine designers to promote loyalty levels of search engine users. This is a descriptive survey study. The statistical population of the research is composed of Ferdowsi University students.
Alireza Hadadian   +3 more
doaj  

PENERAPAN MODEL UTAUT UNTUK MEMAHAMI NIAT MENGGUNAKAN SEARCH ENGINE ADVERTISING PADA PELAKU UMKM PROVINSI BALI

open access: yesE-Jurnal Manajemen, 2019
Tujuan dari penelitian ini adalah untuk meneliti pengaruh ekspektasi kinerja, ekspektasi usaha dan faktor sosial terhadap niat menggunakan search engine advertising. Penelitian ini dilakukan terhadap Pelaku UMKM di Provinsi B gali.
Muhammad Azhari Dadas
doaj   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Special Intelligent Search Engine

open access: yesIranian Journal of Information Processing & Management, 2011
In this paper Special Intelligent Search Engine (SISE) design has been introduced. Also System architecture and methods of this component of its intelligent search engine and features have been described.
Reza Sarabadani, Hossein Shirazi
doaj  

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy